Institutional Ownership
Glaxosmithkline PLC
CUSIP 37733W105SPONSORED ADRQ1 2026
13D / 13G Filings
1
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
5.9%
Max % of class reported
Institutional Holders
5
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
1 filings · latest Feb 14, 2022
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 14, 2022 | Dodge & Cox | 13G | 5.9% | 117.97M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Eads & Heald Wealth Management | 4.0K | $219.2K |
| 2 | Cascades Capital Asset Management, LLC | 1.9K | $104.2K |
| 3 | Asset Planning,Inc | 264 | $14.6K |
| 4 | Byrne Asset Management LLC | 56 | $3.1K |
| 5 | Huntington National Bank | 1 | $40 |